Infections à Vibrio : Questions médicales fréquentes
Nom anglais: Vibrio Infections
Descriptor UI:D014735
Tree Number:C01.150.252.400.959
Termes MeSH sélectionnés :
Exsanguination
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à Vibrio : Questions médicales les plus fréquentes",
"headline": "Infections à Vibrio : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à Vibrio : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à Vibrio"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections bactériennes à Gram négatif",
"url": "https://questionsmedicales.fr/mesh/D016905",
"about": {
"@type": "MedicalCondition",
"name": "Infections bactériennes à Gram négatif",
"code": {
"@type": "MedicalCode",
"code": "D016905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Choléra",
"alternateName": "Cholera",
"url": "https://questionsmedicales.fr/mesh/D002771",
"about": {
"@type": "MedicalCondition",
"name": "Choléra",
"code": {
"@type": "MedicalCode",
"code": "D002771",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.400.959.347"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Infections à Vibrio",
"alternateName": "Vibrio Infections",
"code": {
"@type": "MedicalCode",
"code": "D014735",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bo Peng",
"url": "https://questionsmedicales.fr/author/Bo%20Peng",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocontrol, Guangdong Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China. Electronic address: pengb26@mail.sysu.edu.cn."
}
},
{
"@type": "Person",
"name": "Fei Li",
"url": "https://questionsmedicales.fr/author/Fei%20Li",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science and Technology, Beijing University of Chemical Technology, China; Clinical Laboratory center, Taian City Central Hospital, Taian 271000, China."
}
},
{
"@type": "Person",
"name": "Yigang Tong",
"url": "https://questionsmedicales.fr/author/Yigang%20Tong",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science and Technology, Beijing University of Chemical Technology, China. Electronic address: tong.yigang@gmail.com."
}
},
{
"@type": "Person",
"name": "Jaime Martinez-Urtaza",
"url": "https://questionsmedicales.fr/author/Jaime%20Martinez-Urtaza",
"affiliation": {
"@type": "Organization",
"name": "Department de Genetica I de Microbiologia, Facultat de Biociencies, Universitat Autonoma de Barcelona, Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "C H Ding",
"url": "https://questionsmedicales.fr/author/C%20H%20Ding",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology & Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Contemporary Study of Pre-hospital Traumatic Cardiac Arrest: Distinguishing Exsanguination From Non-exsanguination Arrest With a Review of Current Literature.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/38046709",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.48181"
}
},
{
"@type": "ScholarlyArticle",
"name": "Titratable partial aortic occlusion: Extending Zone I endovascular occlusion times.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37221638",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/TA.0000000000004064"
}
},
{
"@type": "ScholarlyArticle",
"name": "Causes and associations with mortality in patients with pelvic ring injuries with haemorrhagic shock.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36922411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00590-023-03516-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Stop exsanguination by inflation: management of aorta-esophageal fistula bleeding.",
"datePublished": "2024-03-08",
"url": "https://questionsmedicales.fr/article/38463737",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/jscr/rjae120"
}
},
{
"@type": "ScholarlyArticle",
"name": "The use of tourniquet is useful in terms of blood loss and soft tissue damage in arthroscopic anterior cruciate ligament reconstruction: a retrospective study.",
"datePublished": "2023-10-18",
"url": "https://questionsmedicales.fr/article/37853067",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-45159-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections bactériennes et mycoses",
"item": "https://questionsmedicales.fr/mesh/D001423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001424"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections bactériennes à Gram négatif",
"item": "https://questionsmedicales.fr/mesh/D016905"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à Vibrio",
"item": "https://questionsmedicales.fr/mesh/D014735"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à Vibrio - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à Vibrio",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à Vibrio",
"description": "Comment diagnostique-t-on une infection à Vibrio ?\nQuels tests sont utilisés pour identifier Vibrio ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer sans culture ?\nLes antécédents de voyage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à Vibrio",
"description": "Quels sont les symptômes courants d'une infection à Vibrio ?\nLes infections à Vibrio causent-elles des éruptions cutanées ?\nY a-t-il des symptômes graves à surveiller ?\nLes symptômes varient-ils selon la souche de Vibrio ?\nLes symptômes apparaissent-ils rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à Vibrio",
"description": "Comment prévenir les infections à Vibrio ?\nLa cuisson des fruits de mer est-elle suffisante ?\nL'eau potable est-elle un risque ?\nLes voyages en zones à risque nécessitent-ils des précautions ?\nLes personnes à risque doivent-elles être plus prudentes ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à Vibrio",
"description": "Quel est le traitement principal pour les infections à Vibrio ?\nLes antibiotiques sont-ils toujours nécessaires ?\nComment la déshydratation est-elle traitée ?\nY a-t-il des traitements préventifs ?\nLes probiotiques aident-ils dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à Vibrio",
"description": "Quelles sont les complications possibles des infections à Vibrio ?\nLes infections cutanées peuvent-elles s'aggraver ?\nY a-t-il un risque de septicémie ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à Vibrio",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes maladies chroniques augmentent-elles le risque ?\nLa saison influence-t-elle le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014735?mesh_terms=Exsanguination&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à Vibrio ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures de selles et des tests sérologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Vibrio ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cultures bactériennes et des tests PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic, mais des tests sont nécessaires."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer sans culture ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des méthodes moléculaires comme la PCR peuvent être utilisées sans culture."
}
},
{
"@type": "Question",
"name": "Les antécédents de voyage sont-ils importants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents de consommation de fruits de mer ou de baignade en eau contaminée sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection à Vibrio ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre."
}
},
{
"@type": "Question",
"name": "Les infections à Vibrio causent-elles des éruptions cutanées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines souches peuvent provoquer des infections cutanées, surtout après exposition à l'eau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves incluent déshydratation sévère et choc septique, nécessitant une attention médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la souche de Vibrio ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la souche, comme Vibrio cholerae ou Vibrio parahaemolyticus."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à Vibrio ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de consommer des fruits de mer crus et lavez-vous les mains régulièrement."
}
},
{
"@type": "Question",
"name": "La cuisson des fruits de mer est-elle suffisante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cuire les fruits de mer à des températures appropriées tue les bactéries Vibrio."
}
},
{
"@type": "Question",
"name": "L'eau potable est-elle un risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eau non traitée peut être contaminée, évitez de boire de l'eau non purifiée."
}
},
{
"@type": "Question",
"name": "Les voyages en zones à risque nécessitent-ils des précautions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé de prendre des précautions alimentaires et d'hygiène lors de voyages."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être plus prudentes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées doivent éviter les fruits de mer crus et les eaux contaminées."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections à Vibrio ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la réhydratation, souvent accompagné d'antibiotiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils toujours nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas toujours nécessaires, surtout pour les infections légères."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation est-elle traitée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins existent pour certaines souches, mais leur utilisation est limitée."
}
},
{
"@type": "Question",
"name": "Les probiotiques aident-ils dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les probiotiques peuvent aider à restaurer la flore intestinale, mais leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections à Vibrio ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la déshydratation sévère, le choc septique et des infections systémiques."
}
},
{
"@type": "Question",
"name": "Les infections cutanées peuvent-elles s'aggraver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections cutanées peuvent s'aggraver et nécessiter des soins médicaux urgents."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de septicémie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Vibrio peuvent provoquer une septicémie, surtout chez les personnes vulnérables."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes à risque."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une prise en charge médicale rapide, souvent en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'exposition à des eaux contaminées."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et immunodéprimées sont plus susceptibles de développer des infections graves."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques comme le diabète augmentent le risque d'infections à Vibrio."
}
},
{
"@type": "Question",
"name": "La saison influence-t-elle le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'infection augmente pendant les mois chauds, favorisant la prolifération de Vibrio."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Vibrio est endémique augmente le risque d'infection."
}
}
]
}
]
}
Background Traumatic cardiac arrest (TCA) remains a challenging problem in terms of diagnosis and management. This is due to difficulty distinguishing the TCA cause and therefore understanding the pat...
Extending the time to definitive hemorrhage control in noncompressible torso hemorrhage (NCTH) is of particular importance in the battlefield where transfer times are prolonged and NCTH remains the le...
This is a cross-sectional analysis describing pREBOA-PRO zone 1 deployment characteristics at seven level 1 trauma centers in the United States and Canada (March 30, 2021, and June 30, 2022). To compa...
One hundred twenty-two patients pREBOA-PRO patients were included. Most catheters were deployed in zone 1 (n = 89 [73%]) with a median zone 1 total occlusion time of 40 minutes (interquartile range, 2...
Longer zone 1 aortic occlusion times seen with titratable aortic occlusion catheters appear to be driven by the feasibility of controlled partial occlusion. The ability to extend safe aortic occlusion...
Therapeutic/Care Management; Level IV....
High energy pelvic ring injuries are associated with significant morbidity and mortality and can be accompanied by haemorrhagic shock following associated vascular injury. This study evaluated the cau...
This retrospective observational study at a Major Trauma Centre reviewed 938 consecutive adult patients (≥ 18yrs) with pelvic ring injuries between December 2014 and November 2018. Patients with featu...
Of the 102 patients included, all sustained injuries from high energy trauma, and 47.1% underwent a haemorrhage control intervention (Resuscitative Endovascular Balloon Occlusion of the Aorta-REBOA, I...
Haemodynamically unstable patients with pelvic ring injuries have a high mortality rate, but death is usually attributed to other injuries or later complications, and not from acute exsanguination. Th...
Aortoesophageal fistula is rare and typically presents itself to the emergency department as Chiari's Triad of mid-thoracic pain, sentinel arterial hemorrhage, and exsanguination after a symptom-free ...
Whether a tourniquet should be used for anterior cruciate ligament reconstruction (ACLR) when the operative field is secured remains controversial. Little is known about the influence of not using a t...
Total knee arthroplasty (TKA) is associated with significant blood loss and postoperative transfusion. The accelerometer-based navigation (ABN) system guides the bone cutting plane without breaching t...
A total of 66 patients scheduled for SBTKA were randomly allocated to either the ABN or conventional group. Postoperative hematocrit (Hct) level, drainage blood loss, transfusion rate, and amount of p...
The mean calculated total RBC loss in the ABN and conventional group was 669.7 and 630.0 mL, respectively (p = 0.572). There was no significant difference between groups for other evaluated outcome pa...
The total RBC loss and volume of packed red cells transfusion were not significant difference between interventions, which suggest no benefit of the ABN system in reducing blood loss and transfusion i...
The protocol of this study was registered in the Thai Clinical Trials Registry database no. TCTR20201126002 on 26/11/2020....
The Arkansas Trauma System was established by law more than a dozen years ago, and all participating trauma centers are required to maintain red blood cells. Since then, there has been a paradigm shif...
A survey of all trauma centers in the Arkansas TS was conducted, and geospatial analysis was performed. Immediately Available Balanced Blood (IABB) was defined as at least 2 units (U) of thawed plasma...
All 64 trauma centers in the state TS completed the survey. All level I, II, and III Trauma Centers (TCs) maintain RBC, plasma, and platelets, but only half of the level II and 16% of the level III TC...
Only 16% of the trauma centers in Arkansas can provide IABB, and only 61% of the population can reach IABB within 60 minutes. Opportunities exist to reduce the time to balanced blood products by selec...
Gastroduodenal perforation commonly due to spontaneous perforation of a pre-existing peptic ulcer is a surgical emergency. On laparotomy, approximately 60%-70% perforations are duodenal and 15%-20% ga...
Hemorrhagic shock is a clinically challenging disease process with high mortality. When conventional blood products are unable to be administered, oxygen-carrying blood alternatives are sometimes util...
This is a case report of the administration of bovine hemoglobin-based oxygen-carrying red blood cell (RBC) substitute HBOC-201 (HemoPure®) to a patient with post-partum bleeding and hemorrhagic shock...
The patient was successfully resuscitated with HBOC-201 from hemorrhagic shock. She was weaned off of vasopressor support and extubated with the recovery of her baseline mental status within 4 h. Howe...
Resuscitation from hemorrhagic shock with HBOC-201 as an RBC alternative is feasible, but significant challenges remain with the management of sequelae resulting from prolonged low-flow, ischemic stat...
This study aimed to compare the clinical outcomes of silicon ring tourniquets and conventional pneumatic tourniquets in total knee arthroplasty (TKA). The study compared the operation time, total blee...
This prospective comparative study included 30 patients who underwent bilateral simultaneous TKA for degenerative osteoarthritis in August to December 2021. All patients underwent TKA on one side with...
L_TP was significantly longer in the silicon ring tourniquet group compared with that in the pneumatic tourniquet group (20.22 ± 2.74 cm versus 15.12 ± 2.40, p < 0.001). No significant difference was ...
Silicon ring tourniquet application resulted in better clinical outcomes than conventional pneumatic tourniquets in TKA. Because we can obtain a wider surgical field using silicon ring tourniquets wit...
